US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 5.870
  • +0.030+0.51%
Close Apr 18 16:00 ET
254.45MMarket Cap-5590P/E (TTM)

Werewolf Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
21.60%19.94M
-79.39%1.5M
18.65%5.9M
94.82%8.08M
4.46M
16.4M
7.28M
4.97M
4.15M
0
Operating revenue
21.60%19.94M
-79.39%1.5M
18.65%5.9M
94.82%8.08M
--4.46M
--16.4M
--7.28M
--4.97M
--4.15M
--0
Cost of revenue
Gross profit
Operating expense
-16.58%60.45M
-29.32%14.46M
-13.48%15.15M
-26.00%14.15M
8.60%16.69M
44.66%72.46M
14.42%20.46M
26.92%17.51M
74.52%19.12M
106.20%15.37M
Selling and administrative expenses
-0.14%18.67M
4.58%4.81M
-2.91%4.31M
-12.77%4.57M
12.67%4.98M
26.17%18.7M
2.65%4.6M
10.75%4.44M
41.78%5.23M
67.78%4.42M
-General and administrative expense
-0.14%18.67M
4.58%4.81M
-2.91%4.31M
-12.77%4.57M
12.67%4.98M
26.17%18.7M
2.65%4.6M
10.75%4.44M
41.78%5.23M
67.78%4.42M
Research and development costs
-22.29%41.78M
-39.16%9.65M
-17.08%10.84M
-30.99%9.58M
6.95%11.71M
52.43%53.76M
18.35%15.86M
33.54%13.07M
91.15%13.89M
127.22%10.95M
Operating profit
27.75%-40.5M
1.65%-12.96M
26.22%-9.25M
59.48%-6.07M
20.45%-12.22M
-11.92%-56.06M
26.31%-13.18M
9.10%-12.54M
-36.66%-14.97M
-106.20%-15.37M
Net non-operating interest income expense
124.16%4.28M
-18.15%965K
63.74%971K
924.74%994K
3,353.85%1.35M
1,734.62%1.91M
3,567.65%1.18M
998.15%593K
90.20%97K
129.41%39K
Non-operating interest income
288.68%7.42M
248.09%4.1M
63.74%971K
924.74%994K
3,353.85%1.35M
1,734.62%1.91M
3,567.65%1.18M
998.15%593K
90.20%97K
129.41%39K
Non-operating interest expense
--3.14M
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-437.87%-1.14M
-108.57%-6K
-266.67%-5K
-108.90%-25K
-6,812.50%-1.11M
338K
70K
117.65%3K
1,856.25%281K
-16K
Other non- operating income (expenses)
-437.87%-1.14M
-108.57%-6K
-266.67%-5K
-108.90%-25K
-6,812.50%-1.11M
--338K
--70K
117.65%3K
1,856.25%281K
---16K
Income before tax
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
-33.63%-14.59M
-106.36%-15.34M
Income tax
Net income
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
-33.63%-14.59M
-106.36%-15.34M
Net income continuous Operations
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
-33.63%-14.59M
-106.36%-15.34M
Minority interest income
Net income attributable to the parent company
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
13.19%-11.94M
-33.63%-14.59M
-106.36%-15.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
73.35%-53.81M
33.24%-11.93M
13.19%-11.94M
78.49%-14.59M
85.02%-15.34M
Basic earnings per share
43.55%-1.05
15.38%-0.33
42.50%-0.23
73.58%-0.14
39.29%-0.34
83.00%-1.86
40.91%-0.39
21.57%-0.4
86.13%-0.53
85.63%-0.56
Diluted earnings per share
43.55%-1.05
15.38%-0.33
42.50%-0.23
73.58%-0.14
39.29%-0.34
83.00%-1.86
40.91%-0.39
21.57%-0.4
86.13%-0.53
85.63%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 21.60%19.94M-79.39%1.5M18.65%5.9M94.82%8.08M4.46M16.4M7.28M4.97M4.15M0
Operating revenue 21.60%19.94M-79.39%1.5M18.65%5.9M94.82%8.08M--4.46M--16.4M--7.28M--4.97M--4.15M--0
Cost of revenue
Gross profit
Operating expense -16.58%60.45M-29.32%14.46M-13.48%15.15M-26.00%14.15M8.60%16.69M44.66%72.46M14.42%20.46M26.92%17.51M74.52%19.12M106.20%15.37M
Selling and administrative expenses -0.14%18.67M4.58%4.81M-2.91%4.31M-12.77%4.57M12.67%4.98M26.17%18.7M2.65%4.6M10.75%4.44M41.78%5.23M67.78%4.42M
-General and administrative expense -0.14%18.67M4.58%4.81M-2.91%4.31M-12.77%4.57M12.67%4.98M26.17%18.7M2.65%4.6M10.75%4.44M41.78%5.23M67.78%4.42M
Research and development costs -22.29%41.78M-39.16%9.65M-17.08%10.84M-30.99%9.58M6.95%11.71M52.43%53.76M18.35%15.86M33.54%13.07M91.15%13.89M127.22%10.95M
Operating profit 27.75%-40.5M1.65%-12.96M26.22%-9.25M59.48%-6.07M20.45%-12.22M-11.92%-56.06M26.31%-13.18M9.10%-12.54M-36.66%-14.97M-106.20%-15.37M
Net non-operating interest income expense 124.16%4.28M-18.15%965K63.74%971K924.74%994K3,353.85%1.35M1,734.62%1.91M3,567.65%1.18M998.15%593K90.20%97K129.41%39K
Non-operating interest income 288.68%7.42M248.09%4.1M63.74%971K924.74%994K3,353.85%1.35M1,734.62%1.91M3,567.65%1.18M998.15%593K90.20%97K129.41%39K
Non-operating interest expense --3.14M------------------0----------------
Other net income (expense) -437.87%-1.14M-108.57%-6K-266.67%-5K-108.90%-25K-6,812.50%-1.11M338K70K117.65%3K1,856.25%281K-16K
Other non- operating income (expenses) -437.87%-1.14M-108.57%-6K-266.67%-5K-108.90%-25K-6,812.50%-1.11M--338K--70K117.65%3K1,856.25%281K---16K
Income before tax 30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M-33.63%-14.59M-106.36%-15.34M
Income tax
Net income 30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M-33.63%-14.59M-106.36%-15.34M
Net income continuous Operations 30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M-33.63%-14.59M-106.36%-15.34M
Minority interest income
Net income attributable to the parent company 30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M13.19%-11.94M-33.63%-14.59M-106.36%-15.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M73.35%-53.81M33.24%-11.93M13.19%-11.94M78.49%-14.59M85.02%-15.34M
Basic earnings per share 43.55%-1.0515.38%-0.3342.50%-0.2373.58%-0.1439.29%-0.3483.00%-1.8640.91%-0.3921.57%-0.486.13%-0.5385.63%-0.56
Diluted earnings per share 43.55%-1.0515.38%-0.3342.50%-0.2373.58%-0.1439.29%-0.3483.00%-1.8640.91%-0.3921.57%-0.486.13%-0.5385.63%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg